Clinical trial
A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an…
NCT00409838 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00409838 |
|---|---|
| Title | A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate |
| Official title | A Phase III, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Abatacept Administered Intravenously in Korean Subjects With Active Rheumatoid Arthritis While Receiving Methotrexate |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Abatacept, Methotrexate, Placebo |
| Enrollment | 113 |
| Start date | Apr 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Dec 1, 2011 |
| First posted | Dec 11, 2006 |
| Last update posted | Aug 8, 2013 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: